Navigation Links
Beta Release of a New Genetics Website- ItRunsInMyFamily.com
Date:12/18/2008

Health 2.0 website allows users to create their family health history online.

Rochester, NY (PRWEB) December 18, 2008 -- Families share many of the same environmental and genetic influences, which makes family health history an important health indicator. ItRunsInMyFamily.com allows a user to build a family pedigree online and track diseases that run in his or her family. By knowing which diseases run in their family, people can take steps to treat and prevent diseases before they occur. After users complete their family health history online they can save, print or email their family health pedigree to their doctor. The website and tool are free to use.

"Doctors are overburdened and don't have time to create a complete family medical history during a rushed health visit," says Brandon M Welch, M.Sc., founder of ItRunsInMyFamily.com and President/CEO of SGgenomics, Inc. "Our tool makes it easy for patients to create their family history report at home and send it to their healthcare professional before their next appointment."

The beta version allows users to create a five generation pedigree that adheres to standardized pedigree nomenclature used by healthcare professionals. The tool also follows American Health Information Community (AHIC) family history core dataset recommendations for health IT interoperability. The website is hosted on HIPAA compliant servers and uses 128-bit SSL encryption with extended validation. Some features have been disabled or postponed during the beta version.

"The purpose of the ItRunsInMyFamily.com beta release is to test the family health history tool in a real environment," says Lead Flash Developer Daniel Obando, BIT. "We need people to go on, use the tool, tell us what they think and report any bugs so we can fix them before the official release."

The organization will also be monitoring bandwidth and other usage statistics during the beta phase. Beta testers are encouraged to complete a website survey and report bugs through the bug reporting system.

Official release is expected in January 2009. The tool currently tracks 12 diseases including heart disease, cancer, and diabetes. The company invites healthcare providers and organizations to use the site for their clientele and members.    

SGgenomics, Inc.
Founded in 2008, SGgenomics Inc. is a privately held corporation that funds and develops innovative genetic & health-based ideas that specialize in personalized medicine. The company focuses on tools and products that translate new discoveries into consumer-centric applications. By leveraging state-of-the-science discoveries, federal guidance, and market demands, its developments will push forward the frontier of science and technology. ItRunsInMyFamily.com is the first product funded and developed by SGgenomics, Inc.

###

Read the full story at http://www.prweb.com/releases/itrunsinmyfamily/familyhealthhistory/prweb1761694.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
2. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
3. First New York/New Jersey Health Care Report Card Released
4. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
5. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
8. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
9. Verdict One Releases Directory of Board Certified Attorneys for Consumers
10. Academy releases emergency preparedness tools to enable millions more people to shelter in place
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: